IBDEI0CY ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6185,1,3,0)
 ;;=3^LYMPHADENITIS, ACUTE
 ;;^UTILITY(U,$J,358.3,6185,1,4,0)
 ;;=4^683.
 ;;^UTILITY(U,$J,358.3,6185,2)
 ;;=^271897
 ;;^UTILITY(U,$J,358.3,6186,0)
 ;;=289.1^^52^538^13
 ;;^UTILITY(U,$J,358.3,6186,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6186,1,3,0)
 ;;=3^LYMPHADENITIS, CHRONIC
 ;;^UTILITY(U,$J,358.3,6186,1,4,0)
 ;;=4^289.1
 ;;^UTILITY(U,$J,358.3,6186,2)
 ;;=^267995
 ;;^UTILITY(U,$J,358.3,6187,0)
 ;;=780.57^^52^538^16
 ;;^UTILITY(U,$J,358.3,6187,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6187,1,3,0)
 ;;=3^OBSTRUCTIVE SLEEP APNEA
 ;;^UTILITY(U,$J,358.3,6187,1,4,0)
 ;;=4^780.57
 ;;^UTILITY(U,$J,358.3,6187,2)
 ;;=^293933
 ;;^UTILITY(U,$J,358.3,6188,0)
 ;;=782.0^^52^538^17
 ;;^UTILITY(U,$J,358.3,6188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6188,1,3,0)
 ;;=3^PARATHESIA
 ;;^UTILITY(U,$J,358.3,6188,1,4,0)
 ;;=4^782.0
 ;;^UTILITY(U,$J,358.3,6188,2)
 ;;=^35757
 ;;^UTILITY(U,$J,358.3,6189,0)
 ;;=780.50^^52^538^18
 ;;^UTILITY(U,$J,358.3,6189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6189,1,3,0)
 ;;=3^SLEEP DISTURBANCE NOS
 ;;^UTILITY(U,$J,358.3,6189,1,4,0)
 ;;=4^780.50
 ;;^UTILITY(U,$J,358.3,6189,2)
 ;;=^111271
 ;;^UTILITY(U,$J,358.3,6190,0)
 ;;=780.2^^52^538^20
 ;;^UTILITY(U,$J,358.3,6190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6190,1,3,0)
 ;;=3^SYNCOPE
 ;;^UTILITY(U,$J,358.3,6190,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,6190,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,6191,0)
 ;;=519.00^^52^538^22
 ;;^UTILITY(U,$J,358.3,6191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6191,1,3,0)
 ;;=3^TRACHEOSTOMY COMPLICATIONS
 ;;^UTILITY(U,$J,358.3,6191,1,4,0)
 ;;=4^519.00
 ;;^UTILITY(U,$J,358.3,6191,2)
 ;;=^321184
 ;;^UTILITY(U,$J,358.3,6192,0)
 ;;=350.1^^52^538^23
 ;;^UTILITY(U,$J,358.3,6192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6192,1,3,0)
 ;;=3^TRIGEMINAL NEURALGIA
 ;;^UTILITY(U,$J,358.3,6192,1,4,0)
 ;;=4^350.1
 ;;^UTILITY(U,$J,358.3,6192,2)
 ;;=^121978
 ;;^UTILITY(U,$J,358.3,6193,0)
 ;;=780.60^^52^538^9
 ;;^UTILITY(U,$J,358.3,6193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6193,1,3,0)
 ;;=3^FEVER NOS
 ;;^UTILITY(U,$J,358.3,6193,1,4,0)
 ;;=4^780.60
 ;;^UTILITY(U,$J,358.3,6193,2)
 ;;=^336764
 ;;^UTILITY(U,$J,358.3,6194,0)
 ;;=784.59^^52^538^19
 ;;^UTILITY(U,$J,358.3,6194,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6194,1,3,0)
 ;;=3^SPEECH DISTURBANCE NEC
 ;;^UTILITY(U,$J,358.3,6194,1,4,0)
 ;;=4^784.59
 ;;^UTILITY(U,$J,358.3,6194,2)
 ;;=^338287
 ;;^UTILITY(U,$J,358.3,6195,0)
 ;;=786.30^^52^538^11
 ;;^UTILITY(U,$J,358.3,6195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6195,1,3,0)
 ;;=3^HEMOPTYSIS NOS
 ;;^UTILITY(U,$J,358.3,6195,1,4,0)
 ;;=4^786.30
 ;;^UTILITY(U,$J,358.3,6195,2)
 ;;=^339669
 ;;^UTILITY(U,$J,358.3,6196,0)
 ;;=90471^^53^539^1^^^^1
 ;;^UTILITY(U,$J,358.3,6196,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6196,1,2,0)
 ;;=2^90471
 ;;^UTILITY(U,$J,358.3,6196,1,3,0)
 ;;=3^Immunization Administration (use w/ Vacs below)
 ;;^UTILITY(U,$J,358.3,6197,0)
 ;;=90472^^53^539^1.5^^^^1
 ;;^UTILITY(U,$J,358.3,6197,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6197,1,2,0)
 ;;=2^90472
 ;;^UTILITY(U,$J,358.3,6197,1,3,0)
 ;;=3^2 or more Immunization Administration (use w/ Vacs below)
 ;;^UTILITY(U,$J,358.3,6198,0)
 ;;=90632^^53^539^5^^^^1
 ;;^UTILITY(U,$J,358.3,6198,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6198,1,2,0)
 ;;=2^90632
 ;;^UTILITY(U,$J,358.3,6198,1,3,0)
 ;;=3^Hepatitis A Vaccine
 ;;^UTILITY(U,$J,358.3,6199,0)
 ;;=90746^^53^539^7^^^^1
 ;;^UTILITY(U,$J,358.3,6199,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,6199,1,2,0)
 ;;=2^90746
 ;;^UTILITY(U,$J,358.3,6199,1,3,0)
 ;;=3^Hepatitis B Vaccine
